|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.56 USD | -1.55% |
|
+0.08% | +78.23% |
| 13/03 | GSK gets US FDA approval for expanded use of RSV vaccine | RE |
| 10/03 | Moderna, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 09:30 AM |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
rDNA Pharmaceuticals | ||||||||||
Biotechnology | 1.85TCr | 1.93TCr | 684.8Cr | 323.6Cr | 194.4Cr | |||||
Total Assets | 2.47TCr | 2.59TCr | 1.84TCr | 1.41TCr | 1.23TCr | |||||
Interest Expense | -1.8Cr | -2.9Cr | -3.8Cr | -2.4Cr | -1Cr | |||||
Income Tax Expense | 108.3Cr | 121.3Cr | 77Cr | -4.6Cr | 5.4Cr | |||||
CAPEX | -28Cr | -40Cr | -71Cr | -105.1Cr | -19Cr | |||||
EBT | 1.33TCr | 957.5Cr | -394.2Cr | -360.7Cr | -276.8Cr | |||||
D&A | 23Cr | 35Cr | 62Cr | 19Cr | 22Cr | |||||
Operating Income | 1.33TCr | 942Cr | -423.9Cr | -394.5Cr | -307.4Cr | |||||
Net Income | 1.22TCr | 836.2Cr | -471.4Cr | -356.1Cr | -282.2Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 617.7Cr | 515Cr | 189.5Cr | 178.5Cr | 119.9Cr | |||||
Total Assets | 105Cr | 126.7Cr | 156Cr | 153.2Cr | 146.8Cr | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Rest of World | 544.8Cr | 729.8Cr | 359.8Cr | 85Cr | 69Cr | |||||
Total Assets | 1Cr | 3.7Cr | 26Cr | 38Cr | 36Cr | |||||
Europe | 684.6Cr | 681.5Cr | 135.5Cr | 60Cr | 5.3Cr | |||||
Total Assets | 18Cr | 71Cr | 13Cr | 28Cr | 30Cr |
- Stock Market
- Equities
- MRNA Stock
- Financials Moderna, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition